Soticlestat, CAS 1429505-03-2

Product Description: Soticlestat (TAK-935; OV935) is a first-in-class, potent, selective, and orally active cholesterol 24-hydroxylase (CH24H) inhibitor. Soticlestat has the potential for epilepsy syndromes research[1][2].

Applications: Neuroscience-Neuromodulation

Formula: C23H23N3O2

References: [1] Krista Eschbach, et al. Stiripentol for the treatment of seizures in Dravet syndrome. Expert Rev Clin Pharmacol. 2019 May;12(5):379-388./[2]Toshiya Nishi, et al. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice. Sci Rep. 2020 Oct 13;10(1):17081.

CAS Number: 1429505-03-2

Molecular Weight: 373.45

Compound Purity: 99.93

Research Area: Neurological Disease

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: Cytochrome P450

• SKU: MEXHY-109123-10.1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-109123-10.1
• Package Unit: 10 mM/1 ml
• Quantity Unit: STK